Betterlife Pharma Inc (BETRF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 01/31
| 01-2021 | 10-2020 | 07-2020 | 04-2020 | 01-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,201 | -6,691 | -1,094 | 276 | -14,784 |
| Depreciation Amortization | 257 | 208 | 186 | 91 | 1,063 |
| Accounts receivable | -262 | -69 | -57 | -1 | -70 |
| Other Working Capital | -1,156 | -154 | 221 | -216 | 228 |
| Other Operating Activity | 23,001 | 3,298 | -737 | -1,076 | 7,616 |
| Operating Cash Flow | $-5,362 | $-3,408 | $-1,481 | $-926 | $-5,948 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -8 | -8 | -8 | N/A | -410 |
| Net Acquisitions | 19 | 19 | 0 | N/A | -327 |
| Purchase Sale Intangibles | -65 | -66 | -65 | -63 | N/A |
| Other Investing Activity | -65 | -66 | -382 | -63 | -125 |
| Investing Cash Flow | $-54 | $-55 | $-390 | $-63 | $-861 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 449 | 605 | N/A | N/A | -2,453 |
| Debt Repayment | N/A | N/A | N/A | N/A | -207 |
| Common Stock Issued | 2,985 | 1,071 | 617 | N/A | 12,309 |
| Other Financing Activity | -374 | -319 | -223 | -136 | -422 |
| Financing Cash Flow | $3,060 | $1,357 | $394 | $-136 | $9,227 |
| Exchange Rate Effect | 15 | 16 | -2 | 2 | 2 |
| Beginning Cash Position | 2,456 | 2,482 | 2,399 | 2,386 | 57 |
| End Cash Position | 116 | 392 | 920 | 1,264 | 2,477 |
| Net Cash Flow | $-2,340 | $-2,090 | $-1,479 | $-1,123 | $2,420 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,362 | -3,408 | -1,481 | -926 | -5,948 |
| Capital Expenditure | -8 | -8 | -8 | N/A | -410 |
| Free Cash Flow | -5,369 | -3,416 | -1,489 | -926 | -6,357 |